Analysts Question Sun Pharma’s Future Investment Plans As Former CFO Invests In Telenor
This article was originally published in PharmAsia News
Executive Summary
Analysts are divided on whether Sudhir Valia’s investments in Telenor’s new India joint venture may prove to be a backdoor way to indirectly channel funds from Sun Pharma.